The Benefit of Dexmedetomidine on Postoperative Cognitive Function is Unrelated to the Modulation on Peripheral Inflammation: A Single Center, Prospective, Randomized Study.
Dexmedetomidine potentially confers advantage to reduce the incidence of postoperative delirium in surgical patients. Anti-inflammation is another remarkable effect of this sedative drug. In this study, we aimed to investigate whether the effect of dexmedetomidine on the postoperative cognitive function is via inhibiting peripheral inflammation. A prospective, randomized controlled study was conducted with patients 65 years of age or older who received total knee hip arthroplasty from January 2019 to May 2019. The patients were randomly assigned to receive a spinal anesthesia supplemented with propofol or dexmedetomidine for sedation. Incidence of postoperative delirium was the primary endpoint and was determined with the Confusion Assessment Method, and incidence of postoperative cognitive dysfunction was assessed with the Mini-Mental State Examination. Blood samples were collected postoperatively to test the plasma concentrations of IL-6, TNF-α and S100β. 366 patients were randomly assigned to two groups. Patients received dexmedetomidine sedation had lower incidences of postoperative delirium and better postoperative cognitive function than the patients sedated with propofol. There was no difference in postoperative plasma concentrations of TNF-α and IL-6 between the two groups. The concentration of S100β at 48 hours after surgery was higher in patients sedated with propofol than patients received dexmedetomidine sedation. Intraoperative sedation with dexmedetomidine conferred better postoperative neurocognitive function for elderly patients received total knee hip arthroplasty. This effect was unrelated to the modulation of dexmedetomidine on peripheral inflammation.